Dr. Schreiber is the Alumni Endowed Professor of Pathology & Immunology at Washington University School of Medicine and Leader of the Tumor Immunology Program of the Washington University Siteman Cancer Center. He received his undergraduate and graduate training in Biochemistry and Immunology from the State University of New York at Buffalo, and his postdoctoral training in molecular immunology at the Scripps Research Institute in La Jolla, California.
London Research Institute
Dr. I an Kerr has had a long and very distinguished career studying the mechanism of action of the interferons. Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National Institute of Medical Research for many years before moving to Lincoln’s Inn Fields in 1980.
Dr. Kerr has made numerous ground-breaking contributions to our understanding of how interferons alter cellular behavior. Dr. Kerr was made a Fellow of the Royal Society in 1985. Dr. Kerr retired in 2005 as a senior group leader at Lincoln’s Inn Fields, London Research Institute.
Dr. Pitha-Rowe has been interested in the effects viral infection on the expression of cellular genes and in the novel approaches to modulation of the antiviral and anti-inflammatory responses. She received her Ph.D. from the Academy of Sciences, Prague, Czech Republic and did postgraduate training in the Institute of Organic Chemistry and Biochemistry, Prague and at the Johns Hopkins University School of Medicine.